Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "Fid"

967 News Found

Medtronic announces first patient implants for bladder incontinence
Medical Device | March 25, 2022

Medtronic announces first patient implants for bladder incontinence

Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


LifeMine Therapeutics and GSK enter drug discovery and development alliance
Biotech | March 24, 2022

LifeMine Therapeutics and GSK enter drug discovery and development alliance

The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


Paige launches AI software to detect breast cancer metastases in lymph nodes
Digitisation | March 23, 2022

Paige launches AI software to detect breast cancer metastases in lymph nodes

Paige Breast Lymph Node designed to enhance diagnostic accuracy and confidence detecting breast cancer metastases of any size in lymph node tissue


Wipro GE Healthcare bolsters leadership bench in India & South Asia
People | March 23, 2022

Wipro GE Healthcare bolsters leadership bench in India & South Asia

This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Trivitron Healthcare elevates Chandra Ganjoo to Group CEO
People | March 22, 2022

Trivitron Healthcare elevates Chandra Ganjoo to Group CEO

She joined Trivitron Healthcare in 1999 and has held several positions in the organisation


RNAGene and PharmAbcine to develop novel mRNA therapeutics
Biotech | March 21, 2022

RNAGene and PharmAbcine to develop novel mRNA therapeutics

mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody


IQVIA launches OCE+ to deliver AI-driven customer engagement
Digitisation | March 16, 2022

IQVIA launches OCE+ to deliver AI-driven customer engagement

OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams